相关实验视频

Updated: Jun 7, 2025

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

通过CRISPR基编辑生成一个MYH6 (c.4034T > C) 突变的人类胚胎干细胞系

Xiaodong Jiang¹, Qiying Liu¹, Lihui Yang¹

¹Anatomy Teaching and Research Office of the Department of Basic Medicine, ZhengZhou Health Vocational College, Zhengzhou 450100, China.

Stem cell research

|November 14, 2024

概括

我们创造了一种新的人类胚胎干细胞系,具有与高性心肌病 (HCM) 相关的特定MYH6基因突变. 这个工具有助于调查突变.

科学领域:

心血管遗传学心血管遗传学
干细胞生物学干细胞生物学
基因编辑技术的技术

背景情况:

MYH6基因对于成年人心脏中的α-髓酸重链至关重要.
一种特定的MYH6突变 (c.4034T>C,p.Leu1345Pro) 与多变性心肌病 (HCM) 有关,但其因果关系仍然不确定.
确定这种突变在HCM发病过程中的明确作用对于了解这种疾病至关重要.

研究的目的:

为了产生携带MYH6 c.4034T>C突变的人类胚胎干细胞系.
为了利用CRISPR腺基编辑进行精确的基因改造.
创建一个细胞模型来研究MYH6突变在HCM中的功能影响.

主要方法:

使用CRISPR腺基编辑,将MYH6 c.4034T>C突变引入人类胚胎干细胞.
生成的细胞系 (WAe009-A-1D) 的特点是其干细胞特性.
评估了体内差异化潜力以确认多能性.

主要成果:

一个稳定的人类胚胎干细胞系 (WAe009-A-1D) 携带MYH6 c.4034T>C突变成功生成.
突变细胞系保留了正常的形态,多能性和型.
这些细胞表现出了体内分化到所有三个生殖层的能力.

结论:

开发的MYH6突变人类胚胎干细胞系为研究这种特定突变在缩性心肌病中的作用提供了宝贵的工具.
这种细胞模型允许对MYH6相关心脏病进行详细的机制研究.
这一细胞系的成功生成和表征推动了对遗传性心肌病的研究.

更多相关视频

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...